Patents by Inventor Arianne PEREZ GARCIA

Arianne PEREZ GARCIA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Antigen binding molecules and methods of use thereof
    Patent number: 11608517
    Abstract: Isolated antigen binding molecules that specifically binds to a molecule comprising an amino acid sequence selected from the group consisting of GSTSGSGKPGSGEGSTKG (SEQ ID NO: 1), GSGKPGSGEG (SEQ ID NO: 2), GKPGSGEG (SEQ ID NO: 3), SGKPGSGE (SEQ ID NO: 499) and KPGSG (SEQ ID NO: 500) are provided. The antigen binding molecules can be used in the methods provided herein.
    Type: Grant
    Filed: October 29, 2019
    Date of Patent: March 21, 2023
    Assignee: Kite Pharma, Inc.
    Inventors: Jed Wiltzius, Stuart Sievers, Arianne Perez Garcia
  • MODIFIED PLURIPOTENT STEM CELLS AND METHODS OF MAKING AND USE
    Publication number: 20210040449
    Abstract: The disclosure provides a method of generating modified T cells from engineered stem cells for use in an autologous or allogeneic setting for engineered immunotherapy. The knockout of endogenous TCR or HLA expression allows for engineering of modified pluripotent stem cells that reduce or eliminate the risk of Graft versus Host Disease (GVHD), provide resistance to elimination by a recipient's T cells and NK cells, and allow for controllable T cell activity. Thus, this method allows the development of T cells with reduced immune reactivity.
    Type: Application
    Filed: February 15, 2019
    Publication date: February 11, 2021
    Inventors: Eric GSCHWENG, Rajul JAIN, Yong OUYANG, Arianne PEREZ GARCIA, Margo ROBERTS, Ruben ALVAREZ RODRIGUEZ, Drake SMITH, Xingliang ZHOU
  • ANTIGEN BINDING MOLECULES AND METHODS OF USE THEREOF
    Publication number: 20200048681
    Abstract: Isolated antigen binding molecules that specifically binds to a molecule comprising an amino acid sequence selected from the group consisting of GSTSGSGKPGSGEGSTKG (SEQ ID NO: 1), GSGKPGSGEG (SEQ ID NO: 2), GKPGSGEG (SEQ ID NO: 3), SGKPGSGE (SEQ ID NO: 499) and KPGSG (SEQ ID NO: 500) are provided. The antigen binding molecules can be used in the methods provided herein.
    Type: Application
    Filed: October 29, 2019
    Publication date: February 13, 2020
    Inventors: Jed Wiltzius, Stuart Sievers, Arianne Perez Garcia
  • Antigen binding molecules and methods of use thereof
    Patent number: 10501775
    Abstract: Isolated antigen binding molecules that specifically binds to a molecule comprising an amino acid sequence selected from the group consisting of GSTSGSGKPGSGEGSTKG (SEQ ID NO: 1), GSGKPGSGEG (SEQ ID NO: 2), GKPGSGEG (SEQ ID NO: 3), SGKPGSGE (SEQ ID NO: 499) and KPGSG (SEQ ID NO: 500) are provided. The antigen binding molecules can be used in the methods provided herein.
    Type: Grant
    Filed: July 11, 2017
    Date of Patent: December 10, 2019
    Assignee: Kite Pharma, Inc.
    Inventors: Jed Wiltzius, Stuart Sievers, Arianne Perez Garcia
  • ANTIGEN BINDING MOLECULES AND METHODS OF USE THEREOF
    Publication number: 20180016620
    Abstract: Isolated antigen binding molecules that specifically binds to a molecule comprising an amino acid sequence selected from the group consisting of GSTSGSGKPGSGEGSTKG (SEQ ID NO: 1), GSGKPGSGEG (SEQ ID NO: 2), GKPGSGEG (SEQ ID NO: 3), SGKPGSGE (SEQ ID NO: 499) and KPGSG (SEQ ID NO: 500) are provided. The antigen binding molecules can be used in the methods provided herein.
    Type: Application
    Filed: July 11, 2017
    Publication date: January 18, 2018
    Inventors: Jed WILTZIUS, Stuart SIEVERS, Arianne PEREZ GARCIA